Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 3 | 7 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 5 | 2 | 7 |
| 2000 | 3 | 0 | 3 |
| 2001 | 2 | 2 | 4 |
| 2002 | 11 | 1 | 12 |
| 2003 | 11 | 6 | 17 |
| 2004 | 21 | 4 | 25 |
| 2005 | 11 | 9 | 20 |
| 2006 | 16 | 3 | 19 |
| 2007 | 12 | 5 | 17 |
| 2008 | 12 | 4 | 16 |
| 2009 | 19 | 3 | 22 |
| 2010 | 27 | 5 | 32 |
| 2011 | 27 | 7 | 34 |
| 2012 | 45 | 8 | 53 |
| 2013 | 35 | 9 | 44 |
| 2014 | 36 | 10 | 46 |
| 2015 | 44 | 7 | 51 |
| 2016 | 33 | 11 | 44 |
| 2017 | 38 | 16 | 54 |
| 2018 | 31 | 7 | 38 |
| 2019 | 38 | 9 | 47 |
| 2020 | 62 | 8 | 70 |
| 2021 | 59 | 11 | 70 |
| 2022 | 75 | 2 | 77 |
| 2023 | 56 | 3 | 59 |
| 2024 | 58 | 11 | 69 |
| 2025 | 38 | 8 | 46 |
| 2026 | 30 | 6 | 36 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes. 2026 Aug 01; 75(8):1477-1491.
-
Structured Telehealth Community Health Worker-Clinician Feedback and Diabetes Outcomes: A Randomized Clinical Trial. JAMA Intern Med. 2026 Aug 01; 186(8):1012-1021.
-
Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP-1 receptor agonist use. Curr Atheroscler Rep. 2026 Jul 18; 28(1).
-
Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences. J Clin Endocrinol Metab. 2026 Jul 15; 111(8):e1983-e1993.
-
Type 2 diabetes mellitus exacerbates vaginal group B Streptococcus colonization via impaired mucosal cytokine response. mSphere. 2026 Jul 28; 11(7):e0002726.
-
Impaired arginine, citrulline, and glutamine metabolism in type 2 diabetes: insights from a stable isotope study. J Clin Endocrinol Metab. 2026 Jun 17; 111(7):1967-1979.
-
Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors. Curr Opin Nephrol Hypertens. 2026 Sep 01; 35(5):498-503.
-
Evaluating time to treatment intensification among drug na?ve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approaches. Curr Med Res Opin. 2026 Apr; 42(4):699-711.
-
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial. Lancet. 2026 Jun 20; 407(10547):2503-2514.
-
Rates of, Reasons for, and Reactions to Discontinuation of GLP-1 Receptor Agonists: A Narrative Review. Diabetes Obes Metab. 2026 Aug; 28(8):6533-6549.